Grounding Cardio-Oncology in Basic and Clinical Science.
作者信息
Moslehi Javid, Amgalan Dulguun, Kitsis Richard N
机构信息
From Divisions of Cardiovascular Medicine (J.M.) and Oncology (J.M.), Cardio-Oncology Program (J.M.), Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; and Division of Cardiology, Department of Medicine (R.N.K.), Department of Cell Biology (D.A., R.N.K.), Wilf Family Cardiovascular Research Institute (R.N.K.), and Albert Einstein Cancer Center (R.N.K.), Albert Einstein College of Medicine, Bronx, NY.
出版信息
Circulation. 2017 Jul 4;136(1):3-5. doi: 10.1161/CIRCULATIONAHA.117.025393.
Abstract
摘要
相似文献
1
Grounding Cardio-Oncology in Basic and Clinical Science.将心脏肿瘤学建立在基础与临床科学之上。
Circulation. 2017 Jul 4;136(1):3-5. doi: 10.1161/CIRCULATIONAHA.117.025393.
2
How to Develop a Cardio-Oncology Clinic.如何建立一个心脏肿瘤诊所。
Heart Fail Clin. 2017 Apr;13(2):347-359. doi: 10.1016/j.hfc.2016.12.011.
3
Cardio-Immuno-Oncology.心肺免疫肿瘤学。
Circulation. 2020 Jan 14;141(2):87-89. doi: 10.1161/CIRCULATIONAHA.119.042276. Epub 2020 Jan 13.
4
Leveraging Social Media for Cardio-Oncology.利用社交媒体开展心脏肿瘤学研究
Curr Treat Options Oncol. 2020 Aug 13;21(10):83. doi: 10.1007/s11864-020-00775-3.
5
Preface to special issue on: Adiposopathy in Cancer and (Cardio)Metabolic Diseases: an Endocrine Approach - Part 4.关于“癌症与（心血管）代谢疾病中的脂肪病变：内分泌学方法 - 第4部分”特刊前言
Horm Mol Biol Clin Investig. 2015 Jul;23(1):1-4. doi: 10.1515/hmbci-2015-0037.
6
Cardio-oncology: an ongoing evolution.心脏肿瘤学：不断发展
Future Oncol. 2015;11(14):2059-66. doi: 10.2217/fon.15.89.
7
Cardiovascular events in cancer survivors.癌症幸存者的心血管事件。
Semin Oncol. 2019 Dec;46(6):426-432. doi: 10.1053/j.seminoncol.2019.01.007. Epub 2019 Nov 19.
8
Cardio-oncology for the 21st century: introduction.21世纪的心脏肿瘤学：引言
Semin Oncol. 2013 Apr;40(2):145-6. doi: 10.1053/j.seminoncol.2013.01.011.
9
Building bridges: the emerging field of cardio-oncology.搭建桥梁：心脏肿瘤学的新兴领域
Future Cardiol. 2015 Jul;11(4):377-82. doi: 10.2217/FCA.15.37. Epub 2015 Aug 4.
10
Targeting Barriers of Systems of Care in a Growing Multi-disciplinary Field.针对日益多学科领域中照护系统的障碍。
Curr Oncol Rep. 2019 Mar 11;21(4):36. doi: 10.1007/s11912-019-0785-3.
引用本文的文献
1
Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling.过表达的SIRT6可改善阿霉素诱导的心脏毒性，并通过代谢重塑增强治疗效果。
Acta Pharm Sin B. 2023 Jun;13(6):2680-2700. doi: 10.1016/j.apsb.2023.03.019. Epub 2023 Mar 25.
2
Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues.使用动态工程化心脏组织评估阿霉素诱导的心脏毒性中的衰老及其预防
JACC CardioOncol. 2023 May 16;5(3):298-315. doi: 10.1016/j.jaccao.2023.03.012. eCollection 2023 Jun.
3
Doxorubicin and Quercetin Double Loading in Modified MCM-41 Lowered Cardiotoxicity in H9c2 Cardioblast Cells In Vitro.多柔比星和槲皮素双重负载于改性MCM-41可降低体外培养的H9c2成心肌细胞的心脏毒性。
Bioengineering (Basel). 2023 May 24;10(6):637. doi: 10.3390/bioengineering10060637.
4
Cardiac fibrosis in oncologic therapies.肿瘤治疗中的心脏纤维化
Curr Opin Physiol. 2022 Oct;29. doi: 10.1016/j.cophys.2022.100575. Epub 2022 Aug 8.
5
Assessment of mitophagy in human iPSC-derived cardiomyocytes.人诱导多能干细胞衍生心肌细胞中自噬的评估。
Autophagy. 2022 Oct;18(10):2481-2494. doi: 10.1080/15548627.2022.2037920. Epub 2022 Feb 27.
6
Current State of Pediatric Cardio-Oncology: A Review.儿科心脏肿瘤学的现状：综述
Children (Basel). 2022 Jan 19;9(2):127. doi: 10.3390/children9020127.
7
Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.癌症治疗的心脏毒性：关注蒽环类心肌病。
Arterioscler Thromb Vasc Biol. 2021 Nov;41(11):2648-2660. doi: 10.1161/ATVBAHA.121.316697. Epub 2021 Sep 30.
8
Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?用于检测肺癌患者免疫检查点抑制剂相关心脏毒性的炎症生物标志物：准备好进入黄金时代了吗？
JACC CardioOncol. 2020 Sep 15;2(3):503-505. doi: 10.1016/j.jaccao.2020.08.001. eCollection 2020 Sep.
9
A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy.一种 BAX 的小分子变构抑制剂可预防阿霉素诱导的心肌病。
Nat Cancer. 2020 Mar;1(3):315-328. doi: 10.1038/s43018-020-0039-1. Epub 2020 Mar 2.
10
The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity.美国国立卫生研究院资助的心脏肿瘤学研究的不断发展的设计，以解决癌症治疗相关的心血管毒性。
JACC CardioOncol. 2019 Sep;1(1):105-113. doi: 10.1016/j.jaccao.2019.08.007. Epub 2019 Sep 24.
本文引用的文献
1
Cardiovascular Toxic Effects of Targeted Cancer Therapies.靶向癌症治疗的心血管毒性作用
N Engl J Med. 2016 Oct 13;375(15):1457-1467. doi: 10.1056/NEJMra1100265.
2
Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.早期发现蒽环类药物心脏毒性并通过心力衰竭治疗得到改善。
Circulation. 2015 Jun 2;131(22):1981-8. doi: 10.1161/CIRCULATIONAHA.114.013777. Epub 2015 May 6.
3
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation.多柔比星的心脏毒性是通过线粒体铁积累介导的。
J Clin Invest. 2014 Feb;124(2):617-30. doi: 10.1172/JCI72931. Epub 2014 Jan 2.
4
Emerging paradigms in cardiomyopathies associated with cancer therapies.与癌症治疗相关的心肌病的新兴范式。
Circ Res. 2013 Aug 30;113(6):754-64. doi: 10.1161/CIRCRESAHA.113.300218.
5
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.II型化疗相关心脏功能障碍：是时候认识一种新的疾病实体了。
J Clin Oncol. 2005 May 1;23(13):2900-2. doi: 10.1200/JCO.2005.05.827.
Zotero 插件